TB CONTROL IN HEALTHCARE FACILITIES: A PRACTICAL GUIDE FOR PREVENTION

Similar documents
Chapter 7 Tuberculosis Infection Control

TB Infection Control in Healthcare Settings

TB Program Management San Antonio, Texas November 5-7, 2008

TB Transmission, Pathogenesis & Infection Control

2018 Tuberculosis Clinical Intensive: Infection Prevention & Control. > No disclosures

Rebecca O. Sanchez, BSN., RN., MPH. has the following disclosures to make:

Guidelines for Preventing the Transmission of M. tuberculosis in Health-Care Settings, Division of Tuberculosis Elimination

At the end of this session, participants will be able to:

What s New in TB Infection Control?

Issues in TB Infection Control. Stopping transmission of TB. The Issue: Transmission of TB. TB Infection Control

TB Infection Control. Carol Staton, RN, BSN March 17, TB Nurse Case Management March 17 19, 2015 San Antonio, Texas

TB Nurse Case Management San Antonio, Texas March 7 9, TB Infection Control Robert Petrossian March 8, 2012

Minutes required for removal efficiency ACH 99% 99.9% <1 1

The Air We Share: Principles and Practices of TB Infection Control

Standard Precautions & Isolation Precautions. If you have questions about this module, contact the Infection Prevention department at your facility.

TB Clinical Guidelines: Revision Highlights March 2014

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

TB in Corrections Phoenix, Arizona

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB Infection Control. Delvina Mimi Ford, BSN, RN, CCRN-K, has the following disclosures to make:

Tuberculosis Elimination: The Role of the Infection Preventionist

Modes of Transmission of Influenza A H1N1v and Transmission Based Precautions (TBPs)

TB Infection Control

Appendix C. RECOMMENDATIONS FOR INFECTION CONTROL IN THE HEALTHCARE SETTING

CDC Health Advisory 04/29/2009

Protecting Healthcare Workers from TB in Iowa Douglas Hornick, MD September 27, 2011

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

TB Intensive San Antonio, Texas

"GUARDING AGAINST TUBERCULOSIS IN HEALTHCARE FACILITIES"

TB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the

New Standards for an Old Disease:

IH0300: Droplet Precautions. Infection Prevention and Control Section 04H IH0300 (Droplet Precautions) Page 1. EFFECTIVE DATE: September 2006

TIP NO AEROSOLIZED DRUGS TECHNICAL INFORMATION PAPER NO PURPOSE.

TB Infection Control: Fears and Facts Lisa V. Adams, MD Elizabeth A. Talbot, MD Dartmouth Medical School June 2011

Module 3 - TB Infection control incbo

Epidemiology and Risk of Infection in outpatient Settings

Epidemiology and Risk of Infection in outpatient Settings

"GUARDING AGAINST TUBERCULOSIS IN INSTITUTIONAL FACILITIES"

Bulleted Recommendations

PRINCIPLES OF TB CONTROL

Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel

POLICY FOR THE PREVENTION AND CONTROL OF TUBERCULOSIS

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Infection Control Recommendations on Avian Influenza A (H7N9) ICB / CHP

Tuberculosis Procedure ICPr016. Table of Contents

Clinical Practice Guideline

Influenza Outbreak Control Measure Trigger Tool for Care Homes

OBJECTIVES PEOPLE AS RESERVOIRS. Reservoir

Infection Control Standard Precautions and Isolation

Swine Flu. Background. Interim Recommendations. Infectious Period. Case Definitions for Infection with Swine-origin

CHAPTER 3: DEFINITION OF TERMS

TB Contact Investigation

Pandemic Flu: Non-pharmaceutical Public Health Interventions. Denise Cardo,, M.D. Director Division of Healthcare Quality Promotion

TUBERCULOSIS CONTACT INVESTIGATION

TB and Respiratory Protection

2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key

Respiratory Protection and Swine Influenza

The diagnosis of active TB

Fundamentals of Tuberculosis (TB)

Improving Tuberculosis Infection Control

FLORIDA DEPARTMENT OF JUVENILE JUSTICE DETENTION SERVICES FACILITY MEDICAL POLICIES

Vaccine Preventable Respiratory Infections and Tuberculosis

Transmission of Mycobacterium tuberculosis

TB Contact Investigation Basics

During Influenza Season A Checklist for Residential Care Facilities

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department

"GUARDING AGAINST TUBERCULOSIS AS A FIRST RESPONDER"

ICM VI-09 DEFINITION REFERENCES

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Emergency Department and Receiving Areas CHAPTER 24: Author P. Suri, MD R. Gopaul, MD

Disclosure. Objectives

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

TUBERCULOSIS. Pathogenesis and Transmission

ANNEX I: INFECTION CONTROL GUIDELINES FOR PANDEMIC INFLUENZA MANAGEMENT

Contact Investigation

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Prevention and Control of Healthcare-Associated Norovirus

Dr Tara Anderson ACIPC 24 th November 2015

Summary Information for Contact Precautions

Diagnosis and Medical Management of Latent TB Infection

Infection Control for Anesthesia Personnel

Interim Guidance: Infection prevention and control measures for Health Care Workers in Acute Care Facilities

Prevent Measles Example of Fact sheet for health workers in Fiji

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Ministry of Health and Long-Term Care

INSTRUCTOR S GUIDE VERSION

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

CDHB Infection Prevention and Control Community Liaison

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

2009 H1N1 Influenza A Virus EHS&RM

Transmission (How Germs Spread) Module 1

How do I comply with the Influenza Control Program Policy this year?

Infection Prevention and Control (IPC)

AEROSOL TRANSMISSIBLE DISEASE STANDARD. Riverside County Department of Public Health 2010

SUBJECT: ISOLATION PRECAUTIONS REFERENCE #6003 PAGE: 1 DEPARTMENT: REHABILITATION SERVICES OF: 6 EFFECTIVE:

Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel

Infection Prevention To navigate, click the Page Up or Page Down keys on your keyboard

PANDEMIC INFLUENZA PHASE 6 INFECTION CONTROL RECOMMENDATIONS TEMPLATE

on Infectivity of Air on a Hospital Ward

How do I comply with the Influenza Control Program Policy this year?

Transcription:

TB CONTROL IN HEALTHCARE FACILITIES: A PRACTICAL GUIDE FOR PREVENTION

HOW TB IS SPREAD

GENERATION OF TB DROPLET NUCLEI One cough produces 500 droplets Average TB patient generates 75,000 droplets/day (before therapy) Each droplet carries 3-10 bacilli Infectious Dose (ID 50 ) <10 bacilli

DROPLET FATE 1-3 Feet Large Droplets 3-6 Feet Small Droplets 6-150+ Feet Droplet Nuclei

FACTORS DETERMINING TRANSMISSION FACTOR Susceptibility Infectiousness Environment Exposure DESCRIPTION Immune status of the exposed individual Directly related to number of bacilli expelled into the air. Individuals who expel many bacilli are more infectious than those that expel few or no bacilli. Factors that affect the concentration of bacilli in the air (ventilation, circulation, air pressure, etc) Proximity, frequency and duration of exposure

Factor PATIENT CHARACTERISTICS ASSOCIATED WITH INFECTIOUSNESS Description Clinical Persistent cough > 3 weeks Respiratory tract disease, especially laryngeal disease (highly infectious) Failure to cover cough/sneeze Inadequate/Inappropriate treatment Procedure Radiographic and Laboratory Undergoing cough-inducing or aerosol-generating procedure (e.g., bronchoscopy, sputum induction) Cavitation on CXR Positive culture Mtb Postive AFB smear

Factor ENVIRONMENTAL FACTORS - INCREASE TRANSMISSION Description Concentration of droplet nuclei Space The more droplet nuclei in the air, the more probable that Mtb will be transmitted Exposure in small, enclosed spaces Air Circulation Recirculation of air containing droplet nuclei Air Pressure Positive air pressure in infected patients room causes droplet nuclei to flow to other areas

PROGRESSION OF TB People Exposed to Mtb Negative TST or IGRA Infected with Mtb Positive TST or IGRA Does Not Develop LTBI or TB disease Not Infectious Normal CXR No Symptoms Has LTBI Not Infectious May Develop Sx later Abnormal CXR Symptoms May have + Cx Has TB Disease May Be Infectious

INFECTION CONTROL FUNDAMENTALS

HIERARCHY OF INFECTION CONTROL Administrative Controls Reduce the risk of exposure to TB Environmental Controls Prevent spread and reduce concentration of TB droplet nuclei Respiratory Protection Further minimize risk for exposure to TB

TB INFECTION CONTROLS - SIMPLIFIED Administrative WHO? Who is a suspect TB patient? Who is at risk from exposure? Who has infectious TB? Environmental WHERE? Where is the optimal place to minimize risk? Personal Respiratory Protection HOW? How can the worker minimize risk of exposure?

ADMINISTRATIVE CONTROLS Assign responsibility for TB IC Plan Conduct TB risk assessment Develop written TB IC Plan Provide TB screening for HCPs Train HCPs about TB IC Use appropriate signage Train about Respiratory hygiene and cough etiquette

ENVIRONMENTAL CONTROLS Control source of infection Dilute and remove contaminated air Control Airflow and Pressure Keep infectious air moving outside Keep HCPs upwind and infectious patients downwind

AIRBORNE INFECTIOUS ISOLATION ROOM (AIIR) Negative Pressure Clean air flows from corridor into AII room Air cannot escape AII room Air is exhausted outdoors Technical Requirements: 6-12 Air Changes/hr Must be constantly monitored for negative pressure Exhaust grills located above bed

HEPA Filters Remove droplet nuclei from air Must be used with releasing air from: Local exhaust ventilation booth to surrounding areas AII rooms to general ventilation system

UVGI Air cleaning technology that consist of UV lamps, which kill TB bacilli Should be used with other measures UV light can be harmful to skin and eyes

RESPIRATORY PROTECTION (RP) Implement a RP program Written plan Medical Clearance Baseline and annual fit testing required Train HCPs in RP Mask selection User seal check When refit is needed

TB RISK ASSESSMENT

TB RISK ASSESSMENT SETTINGS EXPECTING TO ENCOUNTER TB PATIENTS Review Community TB profile Review number of TB patients encountered Determine which HCPs to include in both TB screening and RP program Assess the number of AIIR needed Determine types of environmental controls needed

TB RISK ASSESSMENT SETTINGS EXPECTING TO ENCOUNTER TB PATIENTS Identify and address areas with increased transmission risk Ensure prompt recognition and evaluation of Mtb transmission Conduct periodic reassessments Gap Analysis idenfies gaps between policy and practice Correct lapses in IC

TB RISK CLASSIFICATIONS Low Risk Persons with TB disease not expected to be encountered; exposure unlikely Medium Risk HCP will or might be exposed to persons with TB disease Potential for Ongoing Transmission Temporary classification for any setting with evidence of person to person transmission of TB

Inpatient Settings Low Medium Potential Ongoing Transmission <200 beds 200 beds <3 TB patients/yr <6 TB patients/yr >3 TB patients/yr >6 TB patients/yr Evidence of ongoing transmission, regardless of setting

Outpatient Settings Low Medium Potential Ongoing Transmission TB treatment facilities, medical offices, ambulatory care settings <3 TB patients/yr >3 TB patients/yr Evidence of ongoing transmission, regardless of setting

Nontraditional Facility-based Settings Low Medium Potential Ongoing Transmission Emergency medical service (EMS), medical settings in correctional facilities, outreach care, long-term care facilities Only patients with LTBI treated No coughinducing procedures are performed in setting Settings where TB patients are expected to be encountered Evidence of ongoing transmission regardless of setting System to detect/triage persons with TB symptoms

TB TESTING FREQUENCY Risk classification Low Medium Potential ongoing transmission Frequency Baseline on hire; further testing not needed unless exposure occurs Baseline, then annually Baseline, then every 8 10 wks until evidence of transmission has ceased

MANAGING TB PATIENTS

PROMPT TRIAGE Primary risk is patient with undiagnosed/unrecognized TB Initiate AII precautions and manage/transfer patients with suspected/confirmed TB Ask about and evaluate for TB Check for signs and symptoms Mask symptomatic patients Separate immunocompromised patients

CRITERIA FOR INITIATING AII PRECAUTIONS Know or suspected pulmonary, laryngeal or miliary (disseminated) TB disease Patients with known or suspected open/draining TB abscesses or have wound drains in place (JP) Gastric Aspirate (pediatrics only) culture positive for TB Rule out TB in differential diagnosis and AFB smears ordered Previously diagnosed smear-positive TB readmissions

CRITERIA FOR DISCONTINUING AII PRECAUTIONS Infectious TB is unlikely and another diagnosis is made OR Patient has 3 consecutive negative AFB smears, and Patient received standard treatment (minimum of 2 weeks), and Patient demonstrates clinical improvement

FREQUENCY OF SPUTUM COLLECTION At least 8 hours apart One collected during early morning Patients with negative smear results may be released from AII in 2 days

AII PRECAUTIONS POLICIES AND PRACTICES All AIIR are single patient rooms with private bathrooms Entry of visitors and staff should be controlled Keep door shut as much as possible; anteroom HCP should wear at least N-95 disposable respirators or PAPR Visitors should be offered N-95 and instructed on use Visitors symptomatic of TB have written evidence of no active disease

AII PRECAUTIONS POLICIES AND PRACTICES Diagnose and Treat in the AII room Educate patients and visitors on AII precautions and ensure compliance Schedule patients with TB disease for procedures when there is a minimum number of patients and HCP present Provide surgical mask for TB patients during transport, in waiting areas, and when others are present

AII rooms should be checked daily when in use. Results should be documented in the patient record

DISCHARGE CONSIDERATIONS Patient can be discharged without 3 negative sputum smears if Follow-up plan and appointment has been made with local TB program Patient is on standard treatment and directly observed therapy (DOT) is arranged Does not reside in a congregate setting No person in home <4 years old or immunocompromised All in household previously exposed Patient willing to stay home until sputum results negative Do not release if high-risk persons will be exposed

CONTACT INVESTIGATIONS

EVALUATING PROBLEMS Conduct contact investigations for problems such as Conversion in TST or BAMT result in HCP TB disease diagnosis in HCP Suspected person-to-person transmission IC lapses exposing HCPs Possible outbreaks identified using automated lab systems

DEFINING EXPOSURE Occupational Exposure occurs when The source has TB disease (pulmonary, laryngeal, milary); TB disease of skin or wound HCP has contact in confined space (same room) or faceto-face contact in open area HCP was not wearing PPE HCP had exposure to microbiologic sample of viable TB without PPE (laboratory exposure)

Objectives CONTACT INVESTIGATION Determine likelihood that transmission occurred Determine extent of transmission Identify exposed individuals and, if possible, source of potential transmission

CONTACT INVESTIGATION Identify factors that could have contributed to transmission Implement interventions Evaluate effectiveness of interventions Ensuring that exposure to TB is terminated and conditions leading to exposure are eliminated

CONCENTRIC CIRCLE 1 st Concentric Circle: Close and high-risk contacts Index Case 2 nd Concentric Circle: Other than close and/or not high risk contacts

OCCUPATIONAL EXPOSURE EVALUATION HCP and other exposed persons screened by symptoms and TST or IGRA as soon as possible after exposure Follow-up testing repeated in 8-10 weeks following exposure, if initial result negative Provide treatment for LTBI or active TB, as appropriate

RESOURCES

www.cdc.gov/tb/

epi.publichealth.nc.gov/cd/diseases/tb.html

epi.publichealth.nc.gov/cd/lhds/manuals/tb/toc.html

www.who.int/topics/tuberculosis/en/

www.cdc.gov/tb/publications/guidelines/infectioncontrol.htm

Questions??